Skip to main content
. 2017 Jul 10;36(44):6143–6153. doi: 10.1038/onc.2017.209

Figure 7.

Figure 7

Graphic model as discussed in the text. PD-1 expression on NK cells is enhanced in digestive cancer patients, and is further induced when stimulated. Ligation of PD-1 on NK cells with PD-L1 on tumor cells inhibits activation PI3K/AKT signaling of NK cells and thus suppresses NK–cell-mediated anti-tumor activity. PD-1/PD-L1 blockade treatment rescues NK-cell function and may benefit digestive cancer patients.